FOXP1 is an androgen-responsive transcription factor that negatively regulates androgen receptor signaling in prostate cancer cells

Biochemical and Biophysical Research Communications

Volumn 374, Issue 2, 2008, Pages 388-393

  Takayama, Kenichi ^a,b,c   Horie Inoue, Kuniko ^c   Ikeda, Kazuhiro ^c   Urano, Tomohiko ^a,b,c   Murakami, Kayoko ^d   Hayashizaki, Yoshihide ^d   Ouchi, Yasuyoshi ^a   Inoue, Satoshi ^a,b,c  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c SAITAMA MEDICAL UNIVERSITY   (Japan)

^d RIKEN YOKOHAMA INSTITUTE   (Japan)

Author keywords

Androgen receptor; FOXP1; Prostate cancer

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; DNA FRAGMENT; FOXO1D PROTEIN; MESSENGER RNA; NUCLEIC ACID BINDING PROTEIN; TRANSCRIPTION FACTOR FKHR;

ARTICLE; BINDING SITE; CANCER CELL; CARCINOGENESIS; CELL STRAIN LNCAP; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DNA SEQUENCE; FOXP1 GENE; GENE; GENE CONTROL; HUMAN; HUMAN CELL; INTRON; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ANDROGENS; BINDING SITES; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRONS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC;

EID: 48349086097     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.07.056     Document Type: Article

References (18)

1. Grossmann M.E., Huang H., and Tindall D.J. Androgen receptor signaling in androgen-refractory prostate cancer. J. Natl. Cancer Inst. 93 (2001) 1687-1697
2. Debes J.D., and Tindall D.J. Mechanism of androgen-refractory prostate cancer. N. Engl. J. Med. 7 (2004) 1488-1490
3. Chen C.D., Welsbie D.S., Tran C., Baek S.H., Chen R., Vessella R., Rosenfeld M.G., and Sawyers C.L. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10 (2004) 33-39
4. Kang Z., Janne O.A., and Palvimo J.J. Coregulator recruitment and histone modification in transcriptional regulation by the androgen receptor. Mol. Endocrinol. 18 (2004) 2633-2648
5. Wang Q., Carroll J.S., and Brown M. Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell 19 (2005) 631-642
6. Gao N., Zhang J., Rao M.A., Case T.C., Mirosevich J., Wang Y., Jin R., Gupta A., Renie P.S., and Matusik R.J. The role of hapatocyte nuclear factor-3α (Forkhead Box A1) and androgen receptor in transcriptional regulation of prostatic genes. Mol. Endocrinol. 17 (2003) 1484-1507
7. Carroll J.S., Liu X.S., Brodsky A.S., Li W., Meyer C.A., Szary A.J., Eeckhoute J., Shao W., Hestermann E.V., Geistelinger T.R., Fox E.A., Silver P.A., and Brown M. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122 (2005) 33-43
8. Lupien M., Eeckhoute J., Meyer C.A., Wang Q., Zhang Y., Li W., Carroll J.S., Liu X.S., and Brown M. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132 (2008) 958-970
9. Chen G., Nomura M., Morinaga H., Matsubara E., Okabe T., Goto K., Yanase T., Zheng H., Lu J., and Nawata H. Modulation of androgen receptor transactivation by FoxH1. J. Biol. Chem. 280 (2005) 36355-36363
10. Li S., Weidenfeld J., and Morrisey E.E. Transcriptional and DNA binding activity of the Foxp1/2/4 family is modulated by heterotypic and homotypic protein interactions. Mol. Cell. Biol. 24 (2004) 809-822
11. Wang B., Lin D., Li C., and Tucker P. Multiple domains define the expression and regulatory properties of Foxp1 forkhead transcriptional repressors. J. Biol. Chem. 278 (2003) 24259-24268
12. Bahnham A.H., Beasley N., and Campo E. The FOXP1 winged helix transcription factor is a novel candidate tumor suppressor gene on chromosome 3p. Cancer Res. 61 (2001) 8820-8829
13. Prown P.J., Ashe S.L., Leich E., Burek C., Barrans S., Fenton J.A., Jack A.S., Pulford K., Rosenwald A., and Banham A.H. Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B-cell-like subtype of DLBCL. Blood 111 (2008) 2816-2824
14. Fox S.B., Brown P., Han C., Ashe S., Leek R.D., Harris A.L., and Banham A.H. Expression of the forkhead transcription factor FOXP1 is associated with estrogen receptor alpha and improved survival in primary human breast carcinomas. Clin. Cancer Res. 10 (2004) 3521-3527
15. Banham A.H., Boddy J., Launchbury R., Han C., Turley H., Malone P.R., Harris A.L., and Fox S.B. Expression of the forkhead transcriptional factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia. Prostate 67 (2007) 1091-1098
16. Takayama K., Kaneshiro K., Tsutsumi S., Horie-Inoue K., Ikeda K., Urano T., Ijichi N., Ouchi Y., Shirahige K., Aburatani H., and Inoue S. Identification of novel androgen response genes in prostate cancer cells by coupling chromatin immunoprecipitation and genomic microarray analysis. Oncogene 26 (2007) 4453-4463
17. Suzuki H., Okunishi R., Hashizume W., Katayama S., Ninomiya N., Osato N., Sato K., Nakamura M., Iida J., Kanamori M., and Hayashizaki Y. Identification of region-specific transcriptional factor genes in the adult mouse brain by medium-scale real-time RT-PCR. FEBS Lett. 573 (2004) 214-218
18. Langaniere J., Deblois G., and Giguere V. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor α1 gene in breast cancer cells. Mol. Endocrinol. 19 (2005) 1584-1592